Sort
50,496 grants matching “lung cancer”
Development of a RUVBL1/2 Inhibitor as a Radiosensitizer and Immune Stimulator for NSCLC
$551,399Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2023 · CA
Development of a RUVBL1/2 Inhibitor as a Radiosensitizer and Immune Stimulator for NSCLC
$551,399Ralf Kittler · Ut Southwestern Medical Center · R01 · FY2025 · CA
Development of antibacterial agents and materials
$551,277Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$551,264Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
RT-SQuARED-M method to study the precise role of mitochondria in the oxidative damage caused by environmental toxins
$551,250Kasturi Mitra · University Of Alabama At Birmingham · R33 · FY2018 · ES
RT-SQuARED-M method to study the precise role of mitochondria in the oxidative damage caused by environmental toxins
$551,248Kasturi Mitra · University Of Alabama At Birmingham · R33 · FY2019 · ES
The Role of Ceramide Kinase in Eicosanoid Synthesis
$551,203Charles E Chalfant · Virginia Commonwealth University · R01 · FY2012 · HL
CCR DNA Sequencing MiniCore
$551,172Kathleen Hartman · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Development of statistical genetics methodology
$551,144Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2013 · HG
CNS Gene Delivery and Imaging in brain Tumor Therapy
$551,127Oregon Health And Science University · R01 · FY2004 · NS
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
$551,095Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
$551,067John V. Heymach · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA
CANCAN-RUTGERS
$551,024Eileen White · Rutgers Biomedical And Health Sciences · OT2 · FY2025 · CA
Project 2: Optimization of HPPH for HNSCC Selectivity
$550,988Ravindra K Pandey · Roswell Park Cancer Institute Corp · P01 · FY2015 · CA
Translation of a Lung Cancer Palliative Care Intervention for Clinical Practice
$550,947Betty R Ferrell · Beckman Research Institute/City Of Hope · R01 · FY2015 · NR
Health Effects of the Standardized Research E-Cigarette for Harm Reduction in Smokers with HIV
$550,942Patricia Ann Cioe · Brown University · U01 · FY2018 · DA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$550,926Marcus W Bosenberg · Yale University · R01 · FY2016 · CA
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers
$550,886Damon J. Vidrine · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Data Processing, Analysis and Modeling Unit
$550,875Dana Pe'er · Sloan-Kettering Inst Can Research · U2C · FY2022 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$550,845Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Tumor selective inhibition of the WNT pathway
$550,824Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Targeting actin dynamics to inhibit airway hypperresponsiveness and inflammation
$550,822Susan J. Gunst · Indiana University Indianapolis · R01 · FY2016 · HL
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
$550,802Mizuki Nishino · Brigham And Women'S Hospital · R01 · FY2019 · CA
Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer
$550,769Pingping Hou · Rutgers Biomedical And Health Sciences · R01 · FY2025 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$550,707David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA